Dr. Starr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1350 Locust Street
Suite 105
Pittsburgh, PA 15219Phone+1 412-232-8840Fax+1 412-232-3690
Summary
- Dr. Matthew Starr is a neurologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Altoona, UPMC Magee-Womens Hospital, UPMC Presbyterian, and UPMC Mercy. He received his medical degree from University of New Mexico School of Medicine and has been in practice 9 years. He specializes in general neurology and cerebrovascular disease.
Education & Training
UPMC Medical EducationFellowship, Vascular Neurology, 2011 - 2012- UPMC Medical Education (Pittsburgh)Residency, Neurology, 2008 - 2011
- UPMC Medical EducationInternship, Internal Medicine, 2007 - 2008
University of New Mexico School of MedicineClass of 2007
Certifications & Licensure
MD State Medical License 2013 - 2025
PA State Medical License 2007 - 2024
NY State Medical License 2017 - 2019
WV State Medical License 2016 - 2019
NM State Medical License 2012 - 2013- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke Start of enrollment: 2018 Jan 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 35 citationsMonitored Anesthesia Care vs Intubation for Vertebrobasilar Stroke Endovascular TherapyAshutosh P Jadhav, Mehdi Bouslama, Amin Aghaebrahim, Leticia C Rebello, Matthew Starr
JAMA Neurology. 2017-06-01 - 315 citationsEfficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.Michael D. Hill, Mayank Goyal, Bijoy K Menon, Raul G. Nogueira, Ryan A McTaggart
Lancet. 2020-03-14 - 33 citationsApixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.Hooman Kamel, W T Longstreth Jr, David L Tirschwell, Richard A Kronmal, Randolph S Marshall
JAMA. 2024-02-20
Journal Articles
- Effect of Alteplase vs Aspirin on Functional Outcome for Patients with Acute Ischemic Stroke and Minor Nondisabling Neurologic DeficitsThe PRISMS Randomized Clinical T...Pooja Khatri, Jeffrey L Saver, Anjan Chatterjee, Joseph Broderick, Edward C Jauch, Steven R Levine, Achala Vagal, Dawn O Kleindorfer, Matthew Starr, JAMA
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
